EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

Salivary CA125, MUC1, VEGF, and sFas as Powerful Diagnostic and Prognostic Tools in Breast Cancer: A Case-Control Study

Mustafa Ahmed Ajeel Alobaidi, Sami Akrem Zbaar

The Medical Journal of Tikrit University · 25.06.2026 · 32 (1) · 74-87

DOI: 10.25130/mjotu.32.1.9 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift The Medical Journal of Tikrit University, online erschienen am 25.06.2026. Verfasst von Mustafa Ahmed Ajeel Alobaidi und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer is the most commonly diagnosed malignancy in women, and early detection is crucial for improving survival rates. Salivary biomarkers offer a promising non-invasive diagnostic approach.

Aim

This study evaluates the diagnostic and prognostic significance of salivary CA125, MUC1, VEGF, and sFas in breast cancer patients, comparing them with blood biomarkers (CA15-3, LDH) and immunohistochemistry (IHC) estrogen and progesterone receptor status.Methodology: This observational case-control study included 270 participants, comprising 225 breast cancer patients (n = 45 per subgroup, ranging from newly diagnosed to Stage IV) and 45 healthy female controls.

Results

Biomarkers were quantified using ELISA, and statistical analyses showed a significant increase (p < 0.001) in CA125, MUC1, VEGF, and sFas as the disease progressed. The ROC curve analysis indicated an AUC of 1.0 for the integrated biomarker panel.

Conclusion

The data suggest that salivary biomarkers, including CA125 and MUC1, are reliable for non-invasive breast cancer screening, and their combination with blood markers enhances diagnostic accuracy.

Zitieren

APA

Alobaidi, M. A. A., & Zbaar, S. A. (2026). Salivary CA125, MUC1, VEGF, and sFas as Powerful Diagnostic and Prognostic Tools in Breast Cancer: A Case-Control Study. The Medical Journal of Tikrit University, 32(1), 74-87. https://doi.org/10.25130/mjotu.32.1.9

Vancouver

Alobaidi MAA, Zbaar SA. Salivary CA125, MUC1, VEGF, and sFas as Powerful Diagnostic and Prognostic Tools in Breast Cancer: A Case-Control Study. The Medical Journal of Tikrit University. 2026;32(1):74-87. doi:10.25130/mjotu.32.1.9

BibTeX
@article{Alobaidi2026,
  author = {Alobaidi, Mustafa Ahmed Ajeel and Zbaar, Sami Akrem},
  title = {Salivary CA125, MUC1, VEGF, and sFas as Powerful Diagnostic and Prognostic Tools in Breast Cancer: A Case-Control Study},
  journal = {The Medical Journal of Tikrit University},
  year = {2026},
  volume = {32},
  number = {1},
  pages = {74--87},
  doi = {10.25130/mjotu.32.1.9}
}
Kostenlos starten →